ScienceDaily

Vitamin C linked to fewer deaths in blood disorder trial

Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An exploratory follow up also found fewer deaths among participants taking vitamin C than among those receiving placebo.

بقلم ScienceDaily

1 دقيقة قراءة
مشاركة
Vitamin C linked to fewer deaths in blood disorder trial
Vitamin C linked to fewer deaths in blood disorder trial

هل لديك أخبار لمشاركتها مع صناعة الفعاليات؟

أرسل بياناً صحفياً أو تلميحاً بقصة وتواصل مع آلاف المهنيين في مجال الفعاليات.

تواصل معنا→

المزيد في Medical Science

رؤى ذات صلة